Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 3
1946 7
1947 5
1948 7
1949 4
1950 15
1951 36
1952 18
1953 29
1954 23
1955 25
1956 145
1957 406
1958 497
1959 398
1960 228
1961 221
1962 212
1963 217
1964 247
1965 168
1966 109
1967 128
1968 164
1969 251
1970 220
1971 209
1972 163
1973 163
1974 156
1975 132
1976 130
1977 109
1978 109
1979 131
1980 104
1981 89
1982 86
1983 113
1984 131
1985 116
1986 125
1987 87
1988 138
1989 131
1990 139
1991 167
1992 168
1993 173
1994 193
1995 400
1996 614
1997 918
1998 1085
1999 1135
2000 1159
2001 1211
2002 1545
2003 1563
2004 1780
2005 2038
2006 2324
2007 2806
2008 2874
2009 3233
2010 3367
2011 3420
2012 3803
2013 3923
2014 4275
2015 4263
2016 4395
2017 4573
2018 4367
2019 4302
2020 4432
2021 4284
2022 3667
2023 3250
2024 697

Text availability

Article attribute

Article type

Publication date

Search Results

79,441 results

Results by year

Filters applied: . Clear all
Page 1
Baby steps.
Oliver N. Oliver N. Diabet Med. 2024 Feb;41(2):e15285. doi: 10.1111/dme.15285. Epub 2024 Jan 10. Diabet Med. 2024. PMID: 38197154 No abstract available.
Drug Therapies for Diabetes.
Weinberg Sibony R, Segev O, Dor S, Raz I. Weinberg Sibony R, et al. Int J Mol Sci. 2023 Dec 5;24(24):17147. doi: 10.3390/ijms242417147. Int J Mol Sci. 2023. PMID: 38138975 Free PMC article. Review.
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy.
Cesta CE, Rotem R, Bateman BT, Chodick G, Cohen JM, Furu K, Gissler M, Huybrechts KF, Kjerpeseth LJ, Leinonen MK, Pazzagli L, Zoega H, Seely EW, Patorno E, Hernández-Díaz S. Cesta CE, et al. JAMA Intern Med. 2024 Feb 1;184(2):144-152. doi: 10.1001/jamainternmed.2023.6663. JAMA Intern Med. 2024. PMID: 38079178 Free PMC article.
Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial.
Boggess KA, Valint A, Refuerzo JS, Zork N, Battarbee AN, Eichelberger K, Ramos GA, Olson G, Durnwald C, Landon MB, Aagaard KM, Wallace K, Scifres C, Rosen T, Mulla W, Valent A, Longo S, Young L, Marquis MA, Thomas S, Britt A, Berry D. Boggess KA, et al. JAMA. 2023 Dec 12;330(22):2182-2190. doi: 10.1001/jama.2023.22949. JAMA. 2023. PMID: 38085312 Clinical Trial.
Glucagon-like peptide agonists: A prospective review.
Mariam Z, Niazi SK. Mariam Z, et al. Endocrinol Diabetes Metab. 2024 Jan;7(1):e462. doi: 10.1002/edm2.462. Epub 2023 Dec 14. Endocrinol Diabetes Metab. 2024. PMID: 38093651 Free PMC article. Review.
New advances in type 1 diabetes.
Subramanian S, Khan F, Hirsch IB. Subramanian S, et al. BMJ. 2024 Jan 26;384:e075681. doi: 10.1136/bmj-2023-075681. BMJ. 2024. PMID: 38278529 Review.
79,441 results
You have reached the last available page of results. Please see the User Guide for more information.